Podcasts about Commercialization

Bayer is reshaping its pharmaceutical business with a new operating model designed to enhance collaboration and bring research & development and commercialization closer together. In a recent episode of The Top Line podcast, Bayer executives Christine Roth, Executive Vice President and Head of Global Product Strategy and Commercialization, and Dr. Yesmean Wahdan, Head of Medical Affairs for the United States and North America, discussed how the company’s Dynamic Shared Ownership framework is driving faster innovation and helping accelerate the development of new therapies for patients. The model removes traditional hierarchies, empowers cross-functional teams and encourages real-time collaboration across departments. Roth and Wahdan said the approach has already shortened regulatory timelines, reduced resource use and helped deliver treatments to patients sooner. By embedding commercial insights early in the research process, Bayer teams can anticipate market needs and focus on the greatest areas of unmet medical demand. The leaders said the company’s collaborative culture keeps patient benefit at the center of decision-making. To learn more about how Bayer’s model is transforming its pipeline, listen to the full episode of The Top Line. See more from Bayer’s Christine Roth and Dr. Yesmean Wahdan on their LinkedIn profiles below: Christine: https://www.linkedin.com/in/christine-roth-34b07b18/ Yesmean: https://www.linkedin.com/in/yesmean-h-wahdan-md-71409b199/ See omnystudio.com/listener for privacy information.

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed. What if drug naming could be faster, smarter and more aligned to brand strategy? In this episode, Addison Whitney's Joe Daley, President, and Bill Purdy, SVP and Managing Director of Global Brand Development & Strategy, break down how Ari™, a purpose-built AI platform, is solving long-standing naming and branding challenges in biopharma. Listen and you'll learn: How Ari™ integrates strategic input, trademark search and POCA screening Ways AI reduces attrition and regulatory risk in naming Why naming is now a strategic process and not just a creative one The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

Oliver Peck and Greg Puciato discuss Better Lovers, Wealth Disparity, The Commercialization of Art and much more... Greg Puciato: Instagram WebsiteJoin our WITD membership program to get access to perks and FREE STUFF:https://www.youtube.com/channel/UCwbve_UjJGYkhio5lEBfSTw/joinOliver Peck:Email your questions... whatintheduckpodcast@gmail.comCameo: https://www.cameo.com/oliverpecker?qid=1731962713&aaQueryId=e538a3265a26fbd2ffa7561fbaab83a1Spotify: https://open.spotify.com/show/3YEUydeJPp3EbUnfkGc50ERumble - https://rumble.com/c/c-6067391Instagram - https://www.instagram.com/oliverpecker/Facebook - https://www.facebook.com/oliverduckypeckerTwitter - https://twitter.com/OLIVER_PECKer?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5EauthorWebsite - https://www.oliverpeckpodcast.comSponsors:Anchor Screen Printing https://www.anchorscreenprinting.comElm Street Tattoo: https://www.elmstreettattoo.com/Cheap Thrills Clothing Brand: https://www.anchorscreenprinting.com/cheap-thrillsYellow Rose Canyon: https://www.yellowrosecanyon.com/Dream Machines of Texas https://www.dreammachinesoftexas.comLegacy Ink email: Legacyartsupplies@gmail.com**WITD Podcast is produced by: Audra Cabral & John NiederkornSound / Video by: Courtney Larkins**

Send us a textHealthcare is drowning in messy, inconsistent data, and IMO Health is helping clean it up so organizations can turn information into real clinical insight.In this CareTalk Executive Feature episode, host David E. Williams speaks with John Laursen, Senior Vice President of Commercialization at IMO Health, about how to separate hype from real value in AI healthcare.

Europe leads the world in discovery — yet too often, its breakthroughs never become global companies.Billions in research funding turn into patents, not products.While others build empires from ideas, Europe risks becoming the world's laboratory — brilliant, but broke.That's the paradox at the heart of this conversation.In this episode, Karl Nehammer, Vice-President of the European Investment Bank (EIB) and former Chancellor of Austria, joins Christian Soschner live at BIO-Europe 2025 to discuss how Europe can turn its world-class science into world-class companies.He shares how leadership forged in crisis can rebuild confidence, competitiveness, and growth — and why every crisis hides an opportunity to start thinking differently.

Liz is joined on the podcast by Becky Lai, Chief Strategist and VP of Marketing, to talk about the true North Star of commercialization: standard of care. Their discussion reframes success as more than building a product—it's about building a market where the product is trusted, adopted, and indispensable. Together, they explore how purposeful training, meaningful KOL engagement, and a clear strategic vision accelerate adoption and move technologies from launch to lasting impact.In 2025, we're embarking on a MedDevice Training Journey: From clinical trials to standard of care. Join us all year long as we explore training at each stage of the product life cycle.Need help developing your clinical trial training strategies? Contact us at training@cumbyconsulting.com.Related Resources:Rebecca Lai is the Chief Strategist and Marketing Executive at Rebecca Lai Consulting. She is a strategy and commercial executive with over 20 years of experience in medical and health technology companies, ranging from venture-backed startups to Fortune 200 corporations. As a dynamic strategic operator specializing in go-to-market, commercialization, and innovative business strategies, she has consistently driven double-digit growth and scaled new businesses with global impact. With a strong background in devices, diagnostics, and the digital transformation of healthcare, Rebecca has a proven track record of pioneering disruptive solutions across the continuum of care. Most recently, she was VP of Corporate Development and Strategy at iRhythm Technologies (NASDAQ:IRTC), a digital healthcare provider of cardiac monitoring services. She began her career at Medtronic (NYSE:MDT), where she held progressive global leadership roles in sales and marketing. Rebecca is recognized for her ability to navigate complexity and her data-driven, customer-centric approach to creating value and delivering cutting-edge products and services to patients worldwide. She holds a BSE and MSE in Bioengineering from the University of Pennsylvania and serves on the advisory board for Diversity by Doing Healthtech.Subscribe to our newsletter to hear more about the journey from clinical trials to standard of care! Click here to subscribe! Connect with us on LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Rebecca Lai⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cumby Consulting⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Rachel Medeiros⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Liz Cumby⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠About Cumby Consulting:Cumby Consulting's team of professionals deliver innovative MedTech training services for physicians, sales representatives, teaching faculty, key opinion leaders and clinical development teams. Whether you need a complete training system developed to deliver revenue sooner or a discrete training program for a specific meeting, Cumby Consulting will deliver highly strategic, efficient programs with uncompromising standards of quality.

Bryan Stobaugh, the Director of Licensing and Commercialization at Missouri Soybeans, says the state soybean checkoff continues to invest in public breeding programs and seed lines to drive innovation. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textWhat is a “Spiritual Rut”?What are some signs that we are in a spiritual rut?Is being in a rut always bad?  What ruts could be considered good or safe?How can we discern if the rut is a “refining season allowed by God” or a “self-inflected” stall in our walk with Christ?How do we get out of those self-inflected ruts?What do we do during those “refining season” ruts?Are spiritual ruts ever caused by a lack of knowing God's will for our lives?  Are there biblical examples of men being in a spiritual rut?  Who?www.LeagueOfLogic.com

374 Water Interim CEO Steve Jones joined Steve Darling from Proactive to discuss his recent appointment as the company's Interim President and Chief Executive Officer. In his new role, Jones will oversee the next stage of project deployments, the commercialization of 374Water's supercritical water oxidation (SCWO) technology, and the acceleration of its expanding pipeline of opportunities in sustainable waste management. Jones, who joined 374Water's Board of Directors in June 2025, brings a wealth of executive experience in environmental services, industrial gases, and clean technologies. His leadership background includes board and senior management roles across several global organizations, where he specialized in commercializing industrial innovations and building high-performing teams in capital-intensive sectors. Previously, Jones served as President, CEO, and Director of Covanta Holding Corporation, a world leader in Energy-from-Waste solutions and environmental services. Before that, he spent a significant portion of his career with Air Products and Chemicals, Inc., a global leader in industrial gases, chemicals, and process technologies. At Air Products, Jones held senior management positions across multiple business units, where he helped pioneer the on-site business model—an approach now being deployed by 374Water as its Waste Destruction Services (“WDS”) model. Jones' background in technology commercialization, business development, and project execution uniquely positions him to guide 374Water through its commercial scale-up phase. His leadership is expected to strengthen the company's focus on transforming waste management through sustainable, closed-loop solutions that convert waste into clean water, energy, and recoverable materials. The appointment marks a strategic step forward for 374Water as it transitions from development to full-scale commercialization of its disruptive, climate-positive waste treatment solutions. The company recently announced the successful completion of a commercial-scale field demonstration at Clean Earth's Detroit, MI facility as part of a previously announced Department of Defense project. In terms of corporate strategy, Jones highlighted a focus on throughput improvements and targeting high-return market opportunities. He also discussed the recent proxy filing regarding a potential reverse stock split to retain Nasdaq listing requirements and broaden investor access. #proactiveinvestors #374waterinc #nasdaq #scwo #wastewater #PFASDestruction #AirSCWO #WasteManagement #EnvironmentalTech #PFAS #WasteDestruction #374Water #EnvironmentalTech #AirSCWO #EPACompliance #WaterTreatment #CleanTech #DefenseInnovation #SustainableSolutions #HazardousWaste #ForeverChemicals #IndustrialWaste #Biosolids

In this episode of Investor Connect, Hall Martin chats with Tim Raines, founder and CEO of Rare Innovation, a boutique consultancy that serves as an outsourced executive team for deep tech startups. Tim shares his extensive experience in science and technology commercialization, helping startups transition from research phases to market-ready products. With expertise in creating go-to-market strategies, product development, and compelling pitch decks, Tim has been pivotal in assisting startups to secure funding and achieve market traction. He discusses the importance of founders making the first sale, early market validation, and adapting communication for various stakeholders, from investors to end-users. Tim also underscores the importance of partnerships and strategic collaborations in navigating limited-resource environments and ensuring successful product commercialization. For founders and investors interested in deep tech, Tim offers valuable insights into the current trends and pitfalls in the ecosystem.    Visit Rare Innovation at Reach out to at   _______________________________________________________ For more episodes from Investor Connect, please visit the site at:    Check out our other podcasts here:   For Investors check out:   For Startups check out:   For eGuides check out:   For upcoming Events, check out    For Feedback please contact info@tencapital.group    Please , share, and leave a review. Music courtesy of .

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.  In this episode, recorded at Fierce Pharma Week 2025, Tyler Cowan, VP Commercial at Syneos Health, joins Hruta Shah, Senior Engagement Manager for Syneos Health Consulting, to break down the high-stakes race in obesity treatment and the commercial boom around GLP-1 therapies.  You'll hear: What emerging launch strategies look like in a crowded, competitive pipeline and how success is being redefined How GLP-1s are accelerating a shift in stakeholder dynamics, including telehealth, large employers and direct-to-patient platforms Why traditional DTC advertising is evolving and how informed patients are influencing brand messaging The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

Early detection saves lives, but today's tools are often invasive, slow, or used too late. In this episode, Breath Diagnostics CEO Ivan Lo explains how a non-invasive breath test can detect volatile organic compounds (VOCs) associated with disease—positioning breath as a first-line screen for early-stage lung cancer and potentially pneumonia and TB. We cover the science (why breath can capture near real-time biological change), sensitivity/specificity signals from 800+ patients, and a go-to-market/regulatory plan that prioritizes post-op pneumonia (shorter trials, no entrenched standard of care) before lung cancer screening. We also discuss platform economics (low-cost disposables, existing LC-MS infrastructure), trial scale and cost, and how breath could support ongoing monitoring after treatment. Investors get a clear view of timelines, risks, and upside; founders get lessons on platform positioning, capital efficiency, and sequencing indications. Highlights include...Why breath (VOCs) can surface disease signals minutes–hours after biological changeFirst-line screening thesis vs. liquid biopsy and CT workflowsEarly data: ~94% sensitivity / 85% specificity across 800+ patients (lung cancer context)Regulatory path: post-op pneumonia first (faster FDA route), lung cancer nextUnit economics: low-cost cartridge + existing LC-MS labs (hub-and-spoke)Clinical design: trial scale, costs, and companion-diagnostic “cocktail” potentialPlatform beyond oncology: pneumonia, TB, inflammation, RUO for pharmaChapters00:00 Intro & why early detection needs a rethink00:47 What Breath Diagnostics does (the “breath bag”)03:34 VOCs 101: why breath can be earlier than blood06:41 First-line screen vs. confirmatory tests08:19 Will this be ubiquitous at annual visits?11:53 Commercialization path & funding realities12:37 Pneumonia first: faster FDA route14:09 Lung cancer timeline & business model15:34 Hospital economics & pneumonia savings18:24 Trial scale/costs; disposable chip economics20:34 Team, funding strategy, and sequencing22:08 Early data and a “false negative” biopsy case24:12 TAM & eligibility (20M Americans qualify)25:06 What success looks like (2–3 years)27:00 Investor closing thoughts

Michael chats with Kathy Lee-Sepsick, CEO and Founder of Femasys. Together, they discuss the founding of Femasys and the products it offers, how Kathy has gone about raising capital for a women's health company despite a challenging lack of sector investment, the importance of gathering thorough safety data for regulatory approvals and commercialization, how Kathy envisions the global commercialization rollout for FemaSeed and FemBloc in the coming months, and much more. To learn more about Femasys and its products, visit Femasys.com.

Pushing biologics beyond 200 mg/mL isn't just a formulation challenge - it's a delivery, manufacturing, and regulatory challenge too. Aggregation, precipitation, and sky-high viscosity make scaling these therapies a gauntlet for drug developers.In this episode of Life Science Solutions, host Chris Adkins continues the conversation on hyper-concentrated biologics with Ryan Doxey, VP of Tech Ops & CMC at Kymanox, and Nick Letourneau, PhD, Associate Director of Product Development & Commercialization. Together, they unpack how dehydrated protein microparticles suspended in hydrophobic carriers (like MCT oils or ethyl oleate) can dissolve instantly upon injection, and why this breakthrough could dramatically ease the patient experience.The conversation dives deep into what this means for manufacturing, device compatibility, and regulatory pathways, revealing how the future of injectables depends on solving problems once thought unsolvable.Topics include:Why ultra-concentrated biologics often fail in aqueous solutionsHow microparticle suspensions dissolve rapidly in vivo to avoid depot effectsRheology 101: viscosity curves, shear-thinning fluids, and device designThe shift to aseptic manufacturing when sterile filtration isn't an optionPreclinical safety considerations and scaling studies from rodents to NHPsWhy early conversations with FDA's Emerging Technology Program matterThis is part two of our deep dive on concentrated biologics - picking up where our Podcast Marathon live episode left off.  This episode offers a rare look inside the formulation frontier — where drug science, delivery design, and patient experience intersect.

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.  Recorded at Fierce Pharma Week 2025, the series begins with a two-part conversation with Mark Bard, co-founder of the Digital Health Coalition. In this episode, Bard joins host Tyler Cowan, VP, Commercial at Syneos Health to unpack how the pandemic reshaped provider expectations and the continued impact on commercial teams. From feedback loops to content fatigue, to the myth of multichannel mastery, they break down what it takes to engage HCPs on their terms. The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.  Recorded at Fierce Pharma Week 2025, the series continues with part two of our conversation with Mark Bard, co-founder of the Digital Health Coalition. In this episode, Bard and host Tyler Cowan turn the lens to patients, exploring how direct-to-patient models are disrupting traditional care and the implications of reduced physician involvement. They also tackle the rise of agentic AI, what it could enable and what commercial teams should be thinking about now. The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

Hillcrest Energy Technologies CEO Don Currie joined Steve Darling from Proactive's OTC studio in New York City to discuss the company's latest milestone, a memorandum of understanding with the Pasqua First Nation. The agreement establishes Pasqua as a strategic partner and prospective investor, marking an important step toward commercialization and long-term growth for Hillcrest. Currie described Hillcrest as a power conversion company focused on its proprietary zero-voltage switching inverter technology, which sets a new standard in efficiency and reliability. “We're the world's only provider of zero voltage switching technology at this power level,” he said. The company's soft-switching innovation dramatically reduces electromagnetic interference (EMI), enhances thermal control, and increases system efficiency making it highly valuable for electric vehicles and data infrastructure. On the automotive side, Hillcrest is collaborating with a global tier-one supplier valued around $3 billion, now nearing the completion of phase one testing. While the EV industry's adoption cycles are lengthy, Currie emphasized the company's expanding focus into faster-moving sectors such as data centers, solar, wind, and energy storage, where its technology offers immediate efficiency advantages. Currie also spoke about Hillcrest's expansion into the U.S. market, noting the strong response the company received after participating in a forum hosted at OTC Markets in New York City. “They understand electrification. They need better electrification here,” he said, highlighting growing demand for advanced power conversion technologies in North America. #proactiveinvestors #hillcrestenergytechnologiesltd #cse #heat #ptcqb #hlrtf #DonCurrie #ElectricVehicles #EVTechnology #PowerConversion #InverterTech #ZeroVoltageSwitching #SoftSwitching #DataCenters #CleanEnergy #PasquaFirstNation #EnergyStorage #GreenTech #ProactiveInvestors

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Chiesi has entered a $2.1 billion collaboration with Arbor to develop a gene therapy for primary hyperoxaluria type 1. AstraZeneca continues to invest in AI partnerships, FDA lifts clinical hold on Neurizon's ALS drug, and the cell and gene therapy field faces challenges and opportunities at the Meeting on the Mesa event. CDC adopts ACIP recommendations, FDA's manufacturing initiatives progress, and Mythic cuts staff.Industry leaders in the cell and gene therapy space are gathering in Phoenix for a meeting on the mesa, where the market is experiencing mixed signals. While M&A activity and regulatory support are showing momentum, challenges with commercialization are still hindering investor interest. The focus on next-generation multiple sclerosis treatments beyond BTK inhibitors is gaining attention, with companies like Immunic Therapeutics exploring neuroprotective targets and remyelination.The future of gene therapy depends on improving safety through targeted delivery and human-relevant testing to avoid costly failures. The FDA has released new guidance to streamline regulatory pathways for cell and gene therapies for small populations, which is receiving a warmer welcome compared to previous issuances. In other news, the US government shut down, leading to the FDA closing for new applications, while Amgen presents late-stage data for Repatha in preventing heart disease.Additionally, Metsera's obesity drug shows promising efficacy in mid-stage trials. Cybersecurity is highlighted as a crucial challenge in the pharmaceutical industry, with a focus on protecting manufacturing integrity and innovation. Upcoming events include webinars on mRNA medicine and biopharma deregulation, while job opportunities in various biopharma companies are also available.Support the show

Bruce Alderman CEO, ROTEC USA | Water Industry Leader | Expert in Commercialization, Sales, and Process Innovation Bruce J. Alderman is a passionate, process-driven leader with a proven record of bringing disruptive water technologies to global industrial and municipal markets. Over his 25+ year career, Bruce has combined technical expertise with commercial insight to drive…More

The FDA Group's Nick Capman speaks with Marwan Fathallah, President and CEO of DIA Global, for a wide-ranging discussion on what it takes to lead effectively across the life science product development cycle—from concept to commercialization.With nearly 30 years of leadership experience spanning pharmaceuticals, medical devices, and diagnostics, Marwan has held senior roles in R&D, regulatory, clinical, scientific affairs, and operations. He brings a rare, holistic view of how leadership, culture, and systems thinking come together to drive successful outcomes in complex, regulated environments.Their conversation explores how to balance innovation and compliance, structure cross-functional teams for consistent execution, and foster cultures that prioritize transparency, collaboration, and patient focus.About The FDA GroupThe FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle—from clinical development to commercialization—with a focus on staff augmentation, auditing, remediation, QMS, and other specialized project work in Quality Assurance, Regulatory Affairs, and Clinical Operations: https://www.thefdagroup.com/

The Commercialization of HATE

In this episode, we chat with Diana Leon-Boys— Assistant Professor of Media and Cultural Studies at the University of Wisconsin-Madison's Department of Communication Arts—about her lifelong work examining the navigation of girlhood through a Latinx lens. Her book Elena, Princesa of the Periphery: Disney's Flexible Latina Girl extends conversations about minority representation and the complex relationship it has with child development. We host a dialogue between Diana's research and Henry's observations about boyhood in his book Where the Wild Things Were: Boyhood and Permissive Parenting in Postwar America. We discuss how both scholars pull from their own personal experiences growing up in America and how they interacted with their childhood media. We explore how the proliferation and production of children's and family media shape ideas of adolescence. Diana and Henry relate this back to their roles as parents within an ever-evolving media landscape where funding for educational children's content is dwindling. They further discuss how representation within media has changed over time and minority groups' relation to it. This is where Diana brings in her newer projects about depictions of Quinceañeras and Día de los Muertos in TV and films. We are left to ask what the politics of childhood are and what reforms can be done with current children's media.Here are some of the references from this episode, for those who want to dig a little deeper:Academic TextsDiana Leon-Boys:Elena, Princesa of the Periphery: Disney's Flexible Latina GirlQuinceañeras: Latinidades and Girlhood in Popular CultureHenry Jenkins:Where the Wild Things Were: Boyhood and Permissive Parenting in Postwar AmericaThe Children's Culture Reader“Just a Spoonful of Sugar: Permissive Child-Rearing and Walt Disney's Mary Poppins”“‘You've Got to Be Carefully Taught': The Whiteness of Permissive Culture”MIT Salute to Doctor SeussInterview about the bookOthers:Centuries of Childhood: A Social History of Family LifeKids in the Middle: How Children of Immigrants Negotiate Community Interactions for Their FamiliesLatina Teenhood: Intersectionalizing subjectivities in the post-network era.Crafting Public Opinion: The Effectiveness of China's Media Control Policies under Xi JinpingMade to Play House: Dolls and the Commercialization of American Girlhood, 1830-1930 Advice Books:The Common Sense Book of Baby and Child CareDare to Discipline  People, Places, Toys, and HolidaysPhilippe ArièsDr. Vikki KatzDía de los MuertosQuinceañerasBenjamin SpockMargaret MeadDr. SeussFred RogersStephanie PérezRaquel Reyes [American Girl Doll]Samantha Parkington [Doll]Julie AndrewsWalt DisneyDisneyland and Disney WorldPaper DollsFDRSigmund Freud Shows, Films, and Other MediaPee-wee's PlayHouseDennis the Menace [59-63' show, Comics]Leave It To BeaverThe Cosby ShowOne Piece [Anime, Manga, Live Action]Disney+EncantoCocoSnow White [Animated, Live Action]Little Mermaid [Animated, Live Action]Chinese State Media sounded like Fox MediaRogue OneSesame StreetGordita ChroniclesBaker and the BeautyBlueyDescendants film franchiseOn My BlockWednesdayMary PoppinsSaludos AmigosHarry Potter film seriesDora The Explorer The 5000 Fingers of Dr. T.Mad Magazine Classic IllustratedGabby's DollhouseQuinceañeras episodesSuper Sweet 16Wizards of Waverly PlaceDora the Explorer  NewsDefunding of PBS Quinceañeras in ProtestOne Piece Flags in Indonesia ––––––––––––––––––––––––––––––Share your thoughts via Twitter with Henry, Colin and the How Do You Like It So Far? account! You can also email us at howdoyoulikeitsofarpodcast@gmail.com.Music:“In Time” by Dylan Emmett and “Spaceship” by Lesion X.In Time (Instrumental) by Dylan Emmet https://soundcloud.com/dylanemmetSpaceship by Lesion X https://soundcloud.com/lesionxbeatsCreative Commons — Attribution 3.0 Unported — CC BY 3.0Free Download / Stream: https://bit.ly/in-time-instrumentalFree Download / Stream: https://bit.ly/lesion-x-spaceshipMusic promoted by Audio Library https://youtu.be/AzYoVrMLa1Q––––––––––––––––––––––––––––––

Welcome back to another episode of The Human Odyssey: A Human-Centered Podcast!On this episode of The Human Odyssey, we're joined by Jacob Croft, Director of Licensing and Commercialization at the University of Texas at El Paso, to discuss how universities, federal agencies, and small businesses align through programs like SBIR and STTR, while also examining which technology initiatives matter most in today's shifting federal funding landscape and how they create real-world impact.This episode of The Human Odyssey was recorded on September 12, 2025.Visit our website: https://sophicsynergistics.com/Follow us on social media!Facebook: https://www.facebook.com/SophicSynergistics/Instagram: https://www.instagram.com/sophicsynergistics/LinkedIn: https://www.linkedin.com/company/sophic-synergistics-llc/Twitter: https://twitter.com/SophicS_LLC

CBS EYE ON THE WORLD WITH JOHN BATCHELOR 1914 BRUSSELS THE SHOW BEGINS IN THE EMERGENCY MEETING IN BRUSSELS ABOUT THE DRONES HARASSING THE EU...... 9-25-25 FIRST HOUR 9-915 Anatol Lieven discusses Trump's UN speech suggesting Europe fund Ukraine war, sparking fear of US disengagement. Escalating Russian drone incidents serve as warnings, while UK politics remain unsettled. 915-930 Anatol Lieven discusses Trump's UN speech suggesting Europe fund Ukraine war, sparking fear of US disengagement. Escalating Russian drone incidents serve as warnings, while UK politics remain unsettled. 930-945 Chris Riegel reports the US leads in AI infrastructure, having over 5,000 advanced data centers, compared to China's 500. China lags due to chip bans, recognizing that data is the new oil. 945-1000 Mary O'Grady reports a Tabasco scandal linking former president AMLO's Morena party and political allies to former security minister Bermúdez, now jailed as an alleged mob boss. SECOND HOUR 10-1015 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1015-1030 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1030-1045 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1045-1100 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. THIRD HOUR 1100-1115    Veronique de Rugy defines industrial policy as central planning using subsidies and tariffs to shape the economy. She argues the US already succeeds best through limited government and free trade principles. 1115-1130 Michael Bernstam explains Russia bypasses US sanctions via balanced ruble-yuan barter trade with China. As a vital energy exporter, punishing Russia's major oil buyers risks ending the world economy. 1130-1145 Cliff May describes wealthy Qatar hosting Hamas leaders, supporting the Muslim Brotherhood, and using Al Jazeerafor sophisticated propaganda. The US tolerates this due to its largest overseas air base in Doha. 1145-1200 Ahmad Sharawi discusses Syria's Al Sharah speaking at the UN seeking sanctions relief and international legitimacy, claiming victory over Assad. He addressed Captagon and accountability, though true judicial reforms are questioned. FOURTH HOUR 12-1215 Paul Mueller critiques industrial policy's resurgence, noting proponents conflate it with pro-market growth. He argues government direction leads to overproduction and resource misallocation, referencing China's EV troubles. 1215-1230 Paul Mueller critiques industrial policy's resurgence, noting proponents conflate it with pro-market growth. He argues government direction leads to overproduction and resource misallocation, referencing China's EV troubles. 1230-1245 Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience. 1245-100 AM Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience. CBS EYE ON THE WORLD WITH JOHN BATCHELOR THE SHOW BEGINS IN THE EMERGENCY MEETING IN BRUSSELS ABOUT THE DRONES HARASSING THE EU...... 9-23-25 FIRST HOUR 9-915 Anatol Lieven discusses Trump's UN speech suggesting Europe fund Ukraine war, sparking fear of US disengagement. Escalating Russian drone incidents serve as warnings, while UK politics remain unsettled. 915-930 Anatol Lieven discusses Trump's UN speech suggesting Europe fund Ukraine war, sparking fear of US disengagement. Escalating Russian drone incidents serve as warnings, while UK politics remain unsettled. 930-945 Chris Riegel reports the US leads in AI infrastructure, having over 5,000 advanced data centers, compared to China's 500. China lags due to chip bans, recognizing that data is the new oil. 945-1000 Mary O'Grady reports a Tabasco scandal linking former president AMLO's Morena party and political allies to former security minister Bermúdez, now jailed as an alleged mob boss. SECOND HOUR 10-1015 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1015-1030 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1030-1045 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1045-1100 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. THIRD HOUR 1100-1115    Veronique de Rugy defines industrial policy as central planning using subsidies and tariffs to shape the economy. She argues the US already succeeds best through limited government and free trade principles. 1115-1130 Michael Bernstam explains Russia bypasses US sanctions via balanced ruble-yuan barter trade with China. As a vital energy exporter, punishing Russia's major oil buyers risks ending the world economy. 1130-1145 Cliff May describes wealthy Qatar hosting Hamas leaders, supporting the Muslim Brotherhood, and using Al Jazeerafor sophisticated propaganda. The US tolerates this due to its largest overseas air base in Doha. 1145-1200 Ahmad Sharawi discusses Syria's Al Sharah speaking at the UN seeking sanctions relief and international legitimacy, claiming victory over Assad. He addressed Captagon and accountability, though true judicial reforms are questioned. FOURTH HOUR 12-1215 Paul Mueller critiques industrial policy's resurgence, noting proponents conflate it with pro-market growth. He argues government direction leads to overproduction and resource misallocation, referencing China's EV troubles. 1215-1230 Paul Mueller critiques industrial policy's resurgence, noting proponents conflate it with pro-market growth. He argues government direction leads to overproduction and resource misallocation, referencing China's EV troubles. 1230-1245 Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience. 1245-100 AM Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience.

Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience. 1959

Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience. 1963

Birchtech Corp (BCHT) Richard MacPherson, CEO; Dr. David Mazyck, Executive Director of Innovation & Commercialization, present at the Gabelli 3rd Annual PFAS Symposium. Moderated by LtCol Tony Bancroft, USMCR (Portfolio Manager). To learn more about Gabelli Funds' fundamental, research-driven approach to investing, visit https://m.gabelli.com/gtv_cu or email invest@gabelli.com. Connect with Gabelli Funds: • X - https://x.com/InvestGabelli • Instagram - https://www.instagram.com/investgabelli/ • Facebook - https://www.facebook.com/InvestGabelli • LinkedIn - https://www.linkedin.com/company/investgabelli/ http://www.Gabelli.com Invest with Us 1-800-GABELLI (800-422-3554)

Die soziologische Theorie ist mit einem Gegenstand befasst, der ständigem Wandel unterliegt. Insofern muss auch sie sich beständig weiterentwickeln, um auf der Höhe der Zeit zu bleiben. Hannah Schmidt-Ott und Jens Bisky sprechen mit der Soziologin Nicole Holzhauser über studentische Theorieaffinität damals und heute, den Streit um das richtige Konzept, posthumane Soziologie, theoretische Konvertiten und politische Renegaten. Und sie fragen: Hat die Identifikation mit Methoden die Leidenschaft für Theorie abgelöst?LiteraturAndreas Reckwitz: „Die Gesellschaft der Singularitäten. Zum Strukturwandel der Moderne“, Suhrkamp 2019.Arlie Russel Hochschild: „The Managed Heart. Commercialization of Human Feeling: Commercialization of Human Feeling“, University of California Press 2012.Bruno Latour: „Das terrestrische Manifest“, Suhrkamp 2018, übersetzt von Bernd Schwibs.Donna Haraway: „Das Manifest für Gefährten“, Merve 2016, übersetzt von Jennifer Sophia Theodor.Pierre Bourdieu: „Die feinen Unterschiede. Kritik der gesellschaftlichen Urteilskraft“, Suhrkamp 1982, übersetzt von Bernd Schwibs und Achim Russer. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Jon LaClare interviews Jim DeBetta, a true retail veteran who has spent decades helping inventors and entrepreneurs bring their products into major retailers.Jim shares his fascinating journey from growing a $20 million retail startup to partnering with Shark Tank's Kevin Harrington as VP of Commercialization—where he helped take winning products straight into stores like Walmart and Costco. Today, Jim focuses on guiding inventors through the complex world of product development, licensing, and retail launches.He opens up about the biggest mistakes first-time entrepreneurs make and explains how to decide between licensing your idea versus bringing it to market yourself. Finally, Jim reveals how LinkedIn has transformed the retail game, making it easier than ever to connect with buyers, and why passion and persistence are key to retail success.In today's episode of the Harvest Growth Podcast, we cover:Why rushing to patent an idea can waste money and kill momentumThe true costs of bringing a product to market and how to plan for themHow to decide whether to license your product or launch it yourselfHow LinkedIn has changed the way inventors connect with retail buyersWhy early market validation is essential before investing heavily in your ideaIf you've ever dreamed of seeing your product on store shelves, or you're weighing the risks and rewards of licensing vs. launching on your own, this episode will give you the clarity and insider knowledge you need. To learn more and get personalized guidance, visit www.jimdebetta.com. To be a guest on our next podcast, contact us today!Do you have a brand that you'd like to launch or grow? Do you want help from a partner that has successfully launched hundreds of brands totaling over $2 billion in revenues? Visit HarvestGrowth.com and set up a free consultation with us today! 

Rohit Nuwal is a Partner at TELUS Global Ventures, Canada's largest and most active corporate venture capital fund, with over 100 investments across transformative sectors such as HealthTech, AgTech, IoT, and AI. In this episode, we explore TELUS' unique approach to commercialization beyond capital — and how they leverage deep insights from their global businesses to provide investment partners with a pathway to real-world traction and growth. Rohit shares how their Strategic Portfolio Development team, combined with a distinctive incentive structure within the core business, accelerates adoption — generating over $100M in P&L value.

Can continuous mindfulness for seven days lead to enlightenment? In this podcast, Bhante Sathi explains that staying mindful for seven continuous days can, in theory, lead to enlightenment, but the challenge lies in overcoming the ego, anger, and distractions that pull us away from mindfulness daily. He emphasizes that mindfulness is a skill requiring consistent practice and determination, and even brief moments of true mindfulness are valuable.

We speak with Rajeeshwaran Moorthy of Space Marketplace at the World Police Summit 2025, held at the Dubai World Trade Centre 13-15 May. Raj is a strategy and technology leader specializing in space economy commercialization, future foresight, and digital transformation. His work focuses on bridging investment, policy, and technology to help organizations navigate complex challenges, develop strategic roadmaps, and capitalize on emerging opportunities—whether in corporate strategy, AI capabilities, or the evolving space economy. Raj spoke tt WPS on Data Intelligence, AI & Surveillance in Narcotics Control which explores the complex and often overlooked issue of drug muling where individuals—sometimes coerced or deceived—find themselves transitioning from victims to accused criminals.Space MarketPlace is a platform dedicated to the space industry, connecting a global community of space professionals, enthusiasts, and businesses. The marketplace offers a wide array of services and applications, ranging from satellite imagery and data analytics to space tourism and satellite launch services.MySecurity Media were media partners to the WPS 2025. #Worldpolicesummit #wps2025 #mysecuritytv

Marriage Contracts: The Sunset Clause Debate sparks a deep dive into the controversial trend of sunset clauses in marriage contracts. Are these renewal clauses a smart way to encourage growth and communication, or do they undermine the sanctity of marriage as a lifelong commitment? We explore the pros, cons, and real-world examples of couples who incorporate these clauses—and their potential impact on relationships. Is this the future of marriage or a fleeting experiment? Join the conversation, share your thoughts, and let us know where you stand on this provocative topic! Get Mobile Marriage Coaching with the Married Into Crazy® App at the Apple App Store or Google Play  #ships #creativewriting #relationshipadvice #mediation #familylaw  CHAPTERS: 00:00 - What is a Sunset Clause 04:22 - Example 1: Driver's License Expiration 10:05 - Example 2: Expiration Date Explained 10:55 - Sunset Clause for Wealthy Individuals 18:18 - Impact of Sunset Clause on Work Ethic 21:05 - Consequences of Not Renewing 21:14 - Marriage as a Contract: Communication vs. Commercialization 23:46 - Closing Remarks 24:48 - Reduced Episode Frequency Announcement

Episode OverviewJoin Sebastian Hassinger in conversation with Deeya Viradia, a Gen Z voice and rising researcher in the quantum computing field. Deeya discusses her multifaceted journey—from early inspiration and undergraduate research to hackathons, quantum clubs, and her ambitions in commercialization. This episode is packed with resources, perspectives on education, and advice for newcomers in quantum technology.Key Topics & HighlightsDeeya's Quantum Origin StoryInspired by curiosity and early science exposure—especially an episode of "Martha Speaks" with Neil deGrasse Tyson—which led to an ongoing passion for exploring the unknown, from astronomy to quantum computing.Found her quantum footing through engineering physics at UC Berkeley and participation in the IBM Qiskit Summer School.Building a Quantum ResumeGained diverse hands-on experience with UC Berkeley's Quantum Devices Group, SLAC (Stanford Linear Accelerator Center), the DoD Quantum Entanglement and Space Technologies (QuEST) Lab, and multiple quantum hackathons (MIT iQuHack Hack, Yale's Y Quantum).Emphasizes the breadth of opportunity for undergraduates—advocates for involvement in hackathons and clubs, even without prior quantum experience.Theory vs. Experiment, and Academia vs. IndustryChallenges traditional boundaries, advocating for integration: understanding both the experimental physics and the theoretical/algorithmic sides of quantum.Describes work at SLAC: optimizing readout for superconducting qubits, working with dilution fridges, and collaborating across national labs and Stanford.Student Community & Entrepreneurial DriveFounded Q-BIT at Berkeley, a club focused on quantum computing applications and industry connections.Active in Berkeley's entrepreneurship community, driven to explore how quantum research moves from lab to commercial product.Commercialization and the Future of QuantumDiscusses the uncertain but promising path to quantum's economic value, highlighting interdisciplinary collaboration, communication, and cross-sector engagement.Strong advocate for students and non-technical communities alike to take risks, reach out, and jump into the field—because quantum needs diverse perspectives and no one knows exactly where it's headed!Resources MentionedIBM Quantum education resourcesIBM Quantum blog - where the summer camp will be announcedMIT iQuHackYale's Y QuantumUnitary FoundationQ-Ctrl Black OpalQ-BIT at BerkeleyQubit by QubitNational Q-12 Education Partnership IEEE Quantum WeekUC Berkeley Quantum Devices GroupSLAC National Accelerator LaboratoryEntrepreneurs @ Berkeley

Pittsburgh's success in the robotics space didn't happen overnight. It's been over 40 years in the making, with education, business, and new innovations all coming together to make the city one of the big robotics hubs alongside Boston and San Francisco.The Pittsburgh Robotics Network has been a key player in that success, giving individuals, companies, and universities the opportunity to collaborate on projects and business opportunities. Executive Director, Jennifer Apicella, joins us on the podcast to give us a background on Pittsburgh's industry and to share her take on the commercialization of robotics and automation.A key theme in this episode is how you don't have to replicate the success of the big cities. Every place is different, and part of Pittsburgh's success has been to lean into its unique strengths and industry challenges. In other words, you don't need your city to become the next Silicon Valley to be successful. In this episode, find out:A recap of the great bars, restaurants and bowling alleys we explored around PittsburghJennifer explains what the Pittsburgh Robotics Network does and how it's helping to support new technology and industry growthSome background on why the Pittsburgh Robotics Network was started and built by the community it now representsHow the group measures success and why commercialization is key to developing technologies that solve real problemsHow other cities and regions can learn from what Pittsburgh has done without needing to copy the same formulaThe challenges of working in a non-profit in a for-profit industry and how Jennifer balances different prioritiesJennifer's advice for becoming a better part of the local technology communityWhy the key to commercialization is about looking beyond the tech and focusing instead on problemsPlans and predictions for Pittsburgh's industry in the next five years Enjoying the show? Please leave us a review here. Even one sentence helps. It's feedback from Manufacturing All-Stars like you that keeps us going!Tweetable Quotes:"I think it's just really important that you stop being obsessed with the technology... rather than being inspired by the technology, be inspired by the problem that it's solving."“Like any kind of industrial revolution, this is going to be largely highly disruptive to all humans. Society is going to change. People are going to change, businesses are going to change. Are you on the right side of that change?”“Commercialization is key. The world is sitting by waiting to see what robotics and autonomy look like at scale. How do you take something and not need it to be custom-built?”Links & mentions:Pittsburgh Robotics Network, a community that connects more than 125 advanced technology companies across multiple industriesIndustrial Solutions Network, an interconnected group of manufacturing technology companies working on a common missionGrapperia Pittsburgh, a cocktail bar with a huge selection of speciality cocktails, grappa and amariUmami Izakaya, a Japanese restaurant and bar serving modern Asian cuisine in PittsburghArsenal Bowl, originally Arsenal Lanes, this bowling alley combines unique décor with live music and...

The institutions are broken because their hearts are broken. In this conversation with Dr. Rick Doblin, president of the Multidisciplinary Association for Psychedelic Studies, we explore whether substances used to great effect in the treatment of PTSD can become the scalpel and the flame for stuck culture—cutting delusion, sparking communion. Physics, like politics, stalls when minds forget how to meet. What if the revolution isn't in data, but in daring to see things in a new light?PATREON https://www.patreon.com/c/demystifysciPARADIGM DRIFThttps://demystifysci.com/paradigm-drift-showMUSICCheck out our band's new album:https://secretaryofnature.bandcamp.com/album/everything-is-so-good-hereVinyl pre-orders available now: https://buy.stripe.com/14A5kC3Od5d21Ms7zPdEs09Multidisciplinary Association for Psychedelic Studies: https://maps.org/00:00 Go! The Challenge of Changing Minds 00:06:32 Introduction to MAPS 00:07:51 Emotional Barriers to New Ideas in Physics 00:12:30 Memory Reconsolidation and Psychedelic Therapy 00:16:48 Truth, Memory, and Emotional Healing 00:20:57 Fragile Beliefs and Resistance to Change 00:21:53 Secondary Gains in PTSD and Self-Healing 00:25:00 Belonging vs Rationality 00:29:00 Load-bearing Beliefs and Instinctive Reactions 00:33:00 Fundamentalism in Institutions and Religion 00:39:00 Reinterpreting Myths and Collective Action 00:44:20 Consciousness Patterns: Team vs Replicator 00:46:00 Embracing the Dualities o2f Human Nature 00:48:54 Culture Shapes Psychedelic Experience 00:51:14 Assumptions and Logical Traps 00:54:00 Ritual, Religion, and Medicalization 00:58:52 Bromo-LSD and Unexpected Healing Paths 01:03:30 New Frontiers in Psychedelic Therapy 01:06:39 Psychedelic Churches and Religious Freedom 01:09:35 Medicalization and Shifting Drug Perceptions 01:15:21 Ancient Mysteries and Psychedelic History 01:19:54 Physicists, Spirit, and Altered States 01:24:30 Jung's Red Book and the Limits of Language 01:28:13 Elite Capture and the Wildfire Metaphor 01:30:54 Capitalism, Collapse, and Redistribution 01:33:21 Innovation Needs a North Star 01:36:54 Uncertainty, Anxiety, and Vision 01:40:22 From Analysis to Action 01:44:11 Self-Transcendence and Collective Awakening 01:49:22 Psychedelics and Social Consciousness 01:56:28 Left, Right, and the Shared Psyche 02:03:51 Dangers of Ego Inflation 02:09:03 The Racist Origins of the Drug War 02:12:26 Post-Prohibition Possibilities 02:14:57 MAPS, Cults, and Therapy Ethics 02:19:51 MAPS Research Methods and Criticisms 02:23:21 Pharma Influence and Scientific Integrity 02:30:07 Ethics and Risk in MDMA Therapy 02:34:27 Commercialization and Mission Drift 02:55:14 Psychedelics, Peace, and Human Growth 02:56:00 Healing Work in Conflict Zones 02:58:00 Psychedelics, Physics, and Collaboration 03:00:00 Nature, Connection, and Future Gatherings #psychedelicscience, #TraumaHealing, #ParadigmShift, #Consciousness, #PsychedelicResearch, #CulturalChange, #SelfTranscendence, #quantumphysics, #physics, #philosophypodcast , #sciencepodcast, #longformpodcast ABOUS US: Anastasia completed her PhD studying bioelectricity at Columbia University. When not talking to brilliant people or making movies, she spends her time painting, reading, and guiding backcountry excursions. Shilo also did his PhD at Columbia studying the elastic properties of molecular water. When he's not in the film studio, he's exploring sound in music. They are both freelance professors at various universities.

GSD Presents: Top Global Startups with Niraj Mathur From Lab to Market: Bridging the Commercialization Gap in Deeptech Startups July 7th, Monday

Redefining leadership requires authenticity, cross-functional collaboration, and a willingness to embrace non-linear career paths. Kari Wilhelm, SVP of Data Strategy and Commercialization at Worldpay, embodies these principles as she navigates the complex intersection of payments technology and data innovation.In this fascinating conversation, Kari reveals how her unconventional journey from economic research in Hong Kong to management consulting at McKinsey ultimately led her to the payments industry. Rather than viewing her diverse background as a limitation, she's leveraged these varied experiences as strategic assets that provide unique perspectives on complex business challenges. As she notes, "I've really experienced that kind of non-linearity as more of a strength rather than a setback."Kari offers profound insights on modern leadership, emphasizing the importance of building inclusive team cultures, setting clear expectations, and providing the necessary tools for success. She highlights how the pandemic has transformed leadership dynamics, creating new challenges for maintaining collaborative environments across dispersed teams. Her practical solutions for adapting leadership approaches in virtual settings demonstrate her thoughtful, pragmatic approach to team management.The conversation explores the unique strengths women bring to payments leadership, particularly their ability to work cross-functionally and build consensus across stakeholders. Kari observes that women often excel at listening deeply to understand underlying needs rather than just surface requests, allowing them to craft solutions that address fundamental issues and build alignment across diverse groups.As leader of Worldpay's data strategy initiatives, Kari provides fascinating glimpses into how AI and data analytics are transforming the payments landscape. Her current focus on leveraging Worldpay's vast transaction data to provide merchant insights represents the cutting edge of payments innovation, with potential to reshape how consumers discover and purchase products.Whether you're a payments veteran, an aspiring leader, or simply curious about the human elements that drive technological innovation, Kari's perspective offers valuable guidance on navigating today's complex business environment with authenticity and purpose.

Niche markets and small populations don't get the attention they need for medtech and healthcare.  Medtech Talk host Swaril Mathur speaks with Eric Chehab, founder and former CEO of Novonate and director of business development of Laborie OB/GYN/NICU, and James Wall, pediatric surgeon and founder of Impact1 at Stanford University, about how they're bringing medtech innovation to small towns and other low-population areas. They delve into their experiences of founding their own niche market companies and the lessons learned, including how they navigated commercialization and acquisition processes, convinced the right investors, determined capital efficiency, and more. They also share their thoughts on investors who think niche solutions for niche markets are uninteresting. Medtech Talk Links:  Cambridge Healthtech Institute   Medtech Talk  Gilde Healthcare  MicroTransponderLinks: MicroTransponder Stanford University Links: Stanford Healthcare Stanford Medicine Children's Health Stanford University Laborie Links: Laborie 

I sat down with Brian H. Davison, PhD, Chief Scientist of Systems Biology & Biotechnology in the Biosciences Division of Oak Ridge National Laboratory and the Center for Bioenergy Innovation. Brian is a graduate of the University of Rochester and Caltech and candidate for President of the American Institute for Chemical Engineering (AIChE). Brian discusses his career trajectory from bench scientist to Chief Scientist, science communication, skills needed for effective leadership, discovery and commercialization, and his long history of leadership in AIChE and what he would aim to accomplish as President.

In this week's podcast, Andreas Munk Holm is joined by Jean Schmitt at Jolt Capital and Rob Blackie at Crampton Blackie to explore one of the most consequential deep tech opportunities Europe faces: RNA. With roots in foundational biology and applications from cancer therapy to precision agriculture, RNA is both a symbol and a stress test of Europe's capacity to scale science into sovereignty.The conversation is based on their Landmark 2025 Report on the State of RNA in Europe, a data-rich, in-depth analysis of patents, funding flows, regulatory bottlenecks, and startup activity across the continent.Here's what's covered:03:05 The State of RNA in Europe05:59 Challenges in Commercialization and Investment09:09 The Landscape of RNA Companies in Europe15:02 Regulatory Challenges in RNA Development17:58 The Future of RNA in Europe26:54 Navigating Regulatory Challenges in Biocontrol Products30:46 The Impact of European Policies on Innovation32:41 Learning from Global Regulatory Practices40:34 The Exodus of Talent and Innovation from Europe45:59 Funding Challenges for RNA Companies in Europe

With all the data at our fingertips, why do so many companies still struggle to deliver truly personalized experiences at scale? Agility requires being able to cut through the noise of data and culture shifts to deliver experiences that truly resonate with each individual.Today we're going to talk about personalization maturity, the role of machine learning, deep learning, and generative AI in driving relevance, and how to future-proof your martech stack with open, flexible architectures that enable best-in-class personalization. To help me discuss this topic, I'd like to welcome Yaniv Navot, Former Dynamic Yield by Mastercard CMO and current SVP of Commercialization for Customer Acquisition & Engagement at Mastercard. About Yaniv Navot Former Dynamic Yield by Mastercard CMO and current SVP of Commercialization for Customer Acquisition & Engagement. He is marketing leader and personalization expert with nearly two decades of experience driving performance-driven marketing at scale. He shaped the personalization market and led the company's rise as an industry leader. Joining as the first marketing hire, Yaniv built a world-class team and partnered with top B2C brands to deliver impactful, cutting-edge personalization strategies. Follow him on LinkedIn: @yanivnavot. Yaniv Navot on LinkedIn: https://www.linkedin.com/in/yanivnavot/ Resources Mastercard: https://www.mastercard.com https://www.mastercard.com The Agile Brand podcast is brought to you by TEKsystems. Learn more here: https://www.teksystems.com/versionnextnow Catch the future of e-commerce at eTail Boston, August 11-14, 2025. Register now: https://bit.ly/etailboston and use code PARTNER20 for 20% off for retailers and brandsDon't Miss MAICON 2025, October 14-16 in Cleveland - the event bringing together the brights minds and leading voices in AI. Use Code AGILE150 for $150 off registration. Go here to register: https://bit.ly/agile150" Connect with Greg on LinkedIn: https://www.linkedin.com/in/gregkihlstromDon't miss a thing: get the latest episodes, sign up for our newsletter and more: https://www.theagilebrand.showCheck out The Agile Brand Guide website with articles, insights, and Martechipedia, the wiki for marketing technology: https://www.agilebrandguide.com The Agile Brand is produced by Missing Link—a Latina-owned strategy-driven, creatively fueled production co-op. From ideation to creation, they craft human connections through intelligent, engaging and informative content. https://www.missinglink.company

In this episode of Plugged In, Abhinav Krishna talks to Joe Hayden, Executive Vice President for North America at GridBeyond, to explore the evolving opportunities and challenges of energy flexibility in today's world. As the conversation dives into how commercial and industrial customers can unlock new revenue streams and support grid stability through demand response programs, Hayden shares why traditional approaches to demand response are being replaced by data-driven, AI-enhanced, and incremental strategies — especially in industries like data centers, cold storage, steel and manufacturing. From the challenges of backup power integration to opportunities in real-time flexibility, Hayden explains where we are in the transformation of the grid's generation and management of costly peak events, and breaks down how GridBeyond helps customers future-proof their energy strategies. You will want to hear this episode if you are interested in... The big picture of what demand-side management looks like today (03:02) What being a qualified scheduled entity looks like in practice (08:54) Learning how isolating “headroom” enhances value (16:00) How GridBeyond's operational DNA helps them anticipate challenges (21:00) Discovering how changing grid conditions impact electricity costs (26:15) AI's role in mitigating the risk of future volatility (27:59) To read full episode show notes, click here. Resources: Grid Beyond Connect with Joe Hayden On LinkedIn Joe Hayden is the VP of Revenue for North America for Dublin, Ireland-based GridBeyond. He has led businesses supporting the electric utility sector for over 20 years and in demand response over the last eight years, during what has been the fourth major electricity grid transformation. Connect with Abhinav Krishna On LinkedIn As Vice President of Commercialization and Development, Abhinav Krishna helps Constellation's customers meet their environment, energy and operational goals. With deep experience coming from 15+ years spent at the forefront of the energy industry in leadership roles across Commercialization, Product Development, Structuring, Risk and many others, he continues to leverage his expertise in sustainability and energy markets to help companies meet their renewable energy and efficiency goals. Connect with Constellation Follow Constellation on LinkedIn Follow Chuck Hanna on LinkedIn Learn more about Constellation sustainability solutions Connect with Smart Energy Decisions Follow us on LinkedInSubscribe to Smart Energy Voices onApple Podcasts, Google Podcasts, Android, Spotify, Stitcher, TuneIn Radio, aCast, PlayerFM, iHeart RadioIf you're interested in participating in the next Smart Energy Decisions Event, visit smartenergydecisions.com or email our Community Development team at attend@smartenergydecisions.com

In this episode of Cybersecurity Today, host Jim Love engages in a comprehensive conversation with Krish Banerjee, the Canada Managing Director at Accenture for AI and Data. They delve into the stark difference between perceived and actual preparedness for cybersecurity in the face of growing AI adoption. The discussion spans topics such as the role of AI in enterprise productivity, the need for better data management, and the integration of AI into various business functions. They also explore the importance of digital sovereignty, the challenges and opportunities in Canada's adoption of AI, and how open-source AI can benefit organizations. Krish emphasizes the significance of setting a clear value-driven goal, having the right tools and talent, and the necessity of adopting AI responsibly. The conversation wraps up with insights on how executives can navigate the AI landscape and prepare their organizations for future advancements. 00:00 Introduction to Cybersecurity and AI Concerns 02:10 Interview with Krish Banerjee: AI in Canada 03:17 The Evolution and Impact of AI 06:42 Enterprise AI: Challenges and Opportunities 15:20 Digital Sovereignty and National AI Strategies 25:07 Accelerating Technological Adoption 26:18 Dream Projects in AI 27:49 AI for Healthcare and Commercialization 31:02 The Future of AI and Economic Impact 35:31 Agentic AI: The Next Frontier 41:14 Open Source AI and Democratization 43:23 Advice for Executives and Parents 49:10 Conclusion and Final Thoughts

Welcome back to the Alt Goes Mainstream podcast.Today's conversation dives into the current state of private markets through the lens of one of the leading GP stakes firms in the industry.We sat down with Partner and Global Co-Head of the Petershill Group at Goldman Sachs Robert Hamilton Kelly. Petershill takes minority equity stakes in established and newly-established alternative asset managers. Across its different investment vehicles, Petershill participates in the fee income from over 200 underlying funds from alternative asset management firms that are diversified across asset class, investment strategy, and investment lifecycle.Petershill's Partner firms have well in excess of $340B in aggregate AUM and they've partnered with a number of the top firms and some of the industry's most recognizable names in the middle market and upper end of the market, including Clearlake, Francisco Partners, Permira, Accel-KKR, General Catalyst, Kayne Anderson Real Estate, Kennedy Lewis, and more.Rob and I had a fascinating conversation on GP stakes and the evolution of alternative asset management. We discussed:The what, why, and how of GP stakes.The benefits and drawbacks of GP stakes investing for GPs and LPs.What makes a great GP.The question of liquidity in GP stakes.Why Petershill has generally focused on middle-market alternative asset managers.How private markets will continue to evolve and the growing importance of the wealth channel in the evolution of asset management.Thanks Rob for coming on the show to share your wisdom and expertise in private markets and GP stakes. We hope you enjoy.A word from AGM podcast sponsor, Ultimus Fund SolutionsThis episode of Alt Goes Mainstream is brought to you by Ultimus Fund Solutions, a leading full-service fund administrator for asset managers in private and public markets. As private markets continue to move into the mainstream, the industry requires infrastructure solutions that help funds and investors keep pace. In an increasingly sophisticated financial marketplace, investment managers must navigate a growing array of challenges: elaborate fund structures, specialized strategies, evolving compliance requirements, a growing need for sophisticated reporting, and intensifying demands for transparency.To assist with these challenging opportunities, more and more fund sponsors and asset managers are turning to Ultimus, a leading service provider that blends high tech and high touch in unique and customized fund administration and middle office solutions for a diverse and growing universe of over 450 clients and 1,800 funds, representing $500 billion assets under administration, all handled by a team of over 1,000 professionals. Ultimus offers a wide range of capabilities across registered funds, private funds and public plans, as well as outsourced middle office services. Delivering operational excellence, Ultimus helps firms manage the ever-changing regulatory environment while meeting the needs of their institutional and retail investors. Ultimus provides comprehensive operational support and fund governance services to help managers successfully launch retail alternative products.Visit www.ultimusfundsolutions.com to learn more about Ultimus' technology enhanced services and solutions or contact Ultimus Executive Vice President of Business Development Gary Harris on email at gharris@ultimusfundsolutions.com.We thank Ultimus for their support of alts going mainstream.Show Notes00:00 Introduction and Sponsor Message01:18 Podcast Opening and Theme02:06 Guest Introduction: Robert Hamilton Kelly03:32 Rob's Boat Racing Experience03:45 Parallels Between Boat Racing and Private Markets04:57 Current State of Private Markets05:14 Impact of Policy Changes on Private Markets06:53 Growth of the Private Markets Industry07:09 Early Days of Petershill07:26 Goldman's Role in Alternative Asset Management09:26 Valuing GP Stakes and Alternative Asset Managers10:01 Insights on Alternative Asset Managers12:36 Valuing GP Stakes13:22 Data-Driven Investment Strategies15:34 Management Fees and Performance Fees16:28 Growth and Evolution of Firms23:16 Strategic Imperatives for Growth26:15 Managerial Skills and Industry Dynamics30:55 Commercialization in Platform Management31:07 Challenges and Opportunities in Capital Raising31:53 Industry Consolidation Predictions32:29 Growth and Consolidation in Private Markets33:31 The Role of Mid-Market Firms34:15 GP Stakes and Wealth Channel Access36:12 Goldman's Unique Platform and Services37:57 The Importance of Strategic Advice39:39 Common Challenges for GPs40:33 Evolving LP and GP Stakes Dynamics40:44 Why LPs Invest in GP Stakes42:00 Income Generation and Capital Growth42:49 Diversification in GP Stakes43:05 Private Markets Exposure44:01 Entry Points into Private Markets45:07 Long-Term Exposure and Portfolio Construction47:00 Investing in Private Credit48:10 Evaluating GP Stakes Investments49:38 Data and Performance in GP Stakes52:04 Growth Path of Private Markets52:23 Valuing Alternative Asset Managers55:41 Liquidity in GP Stakes57:09 Structural Changes in GP Stakes57:35 The Evolution of Private Markets58:11 Future of Venture and Growth Sectors58:56 Private Credit Products and Market Share59:29 Maturation of Private Markets59:52 Conclusion and Final Thoughts

Even before we're aware of heart trouble, our bodies give off warning signs in the form of vibrations.

Still feeling unsure- even with experience under your belt? This episode explains why doubt might be the best sign you're doing the job well, not a reason to second-guess yourself.In this episode, we're pulling back the curtain on what that uncertainty in school counseling really means. We'll talk about the invisible labor of school counseling, what the research says about feedback-poor environments, and how self-doubt often shows up right when your skills are leveling up.You'll learn:Why experienced counselors question themselves more, not lessHow silence and lack of validation chip away at even the strongest counselorsWhy messy, imperfect work is often the most effectiveAnd how to chase credibility instead of certaintyYou're not failing; you're growing. And you're not alone.Mentioned in this episode:School for School Counselors MastermindFree School Counselor PlannerReferences:Culbreth, J. R., Scarborough, J. L., Banks‑Johnson, S. B., & Solomon, T. (2005). Role stress among practicing school counselors. Professional School Counseling, 9(2), 106–112. Dunning, D., & Kruger, J. (1999). Unskilled and unaware of it: How difficulties in recognizing one's own incompetence lead to inflated self-assessments. Journal of Personality and Social Psychology, 77(6), 1121–1134. Falender, C. A., & Shafranske, E. P. (2010). Psychotherapy‑based supervision models in an emerging competency‑based era: A commentary. Psychotherapy: Theory, Research, Practice, Training, 47(1), 45–50. Hill, C. E., Sullivan, C., Knox, S., & Schlosser, L. Z. (2007). Therapist self‑disclosure: Research-based suggestions regarding clinical training, practices, and ethics. Psychotherapy Theory, Research, Practice, Training, 44(4), 392–407. Hochschild, A. R. (1983). The managed heart: Commercialization of human feeling. University of California Press. Jennings, L., & Skovholt, T. M. (2016). In T. M. Skovholt & K. Rønnestad (Eds.), Master therapists: Exploring expertise in therapy and counseling. Routledge. Skovholt, T. M., & Trotter‑Mathison, M. (2016). The resilient practitioner: Burnout prevention and self‑care strategies for counselors, therapists, teachers, and health professionals (3rd ed.). Taylor & Francis. (Original concept described in earlier editions as an “ambiguity‑rich, feedback‑poor environment.”) *********************************⭐️ Want support with real-world strategies that actually work on your campus? We're doing that every day in the School for School Counselors Mastermind. Come join us! ⭐️**********************************Our goal at School for School Counselors is to help school counselors stay on fire, make huge impacts for students, and catalyze change for our roles through grassroots advocacy and collaboration. Listen to get to know more about us and our mission, feel empowered and inspired, and set yourself up for success in the wonderful world of school counseling.Hang out in our Facebook groupJump in, ask questions, share your ideas and become a part of the most empowering school counseling group on the planet! (Join us to see if we're right.)Join the School for School Counselors MastermindThe Mastermind is packed with all the things your grad program never taught you I

Welcome to episode #987 of Six Pixels of Separation - The ThinkersOne Podcast. Cindy Anderson is on a mission to bring clarity, standards, and serious business impact to thought leadership. As Global Lead for Engagement & Eminence at IBM's Institute for Business Value and the Global Thought Leadership Institute, Cindy has spent years leading one of the most ambitious research efforts ever undertaken on this topic. The result is her new book, The ROI of Thought Leadership – Calculating the Value That Sets Organizations Apart, co-authored with Anthony Marshall. In it, Cindy reveals what more than 4000 C-level executives told IBM about how they consume, value, and act on thought leadership, and why some content drives sales while most gets ignored. In this conversation, we unpack what truly makes someone a thought leader, why AI is simultaneously diluting and accelerating the field, and what it means to play at the top of the marketing funnel with 156% ROI on the line. This isn't about personal branding... it's about strategic business outcomes. We also explore how trust, frequency and format shape impact, and what companies must do to avoid audience fatigue. For anyone who creates, funds or is trying to measure thought leadership this one's essential listening. Enjoy the conversation… Running time: 55:18. Hello from beautiful Montreal. Listen and subscribe over at Apple Podcasts. Listen and subscribe over at Spotify. Please visit and leave comments on the blog - Six Pixels of Separation. Feel free to connect to me directly on Facebook here: Mitch Joel on Facebook. Check out ThinkersOne. or you can connect on LinkedIn. ...or on X. Here is my conversation with Cindy Anderson. The ROI of Thought Leadership – Calculating the Value That Sets Organizations Apart. Institute for Business Value. Global Thought Leadership Institute. Anthony Marshall. Follow Cindy on LinkedIn. Chapters: (00:00) - Introduction to Thought Leadership and Its Importance. (03:00) - Challenges in Measuring Thought Leadership ROI. (05:52) - Defining Thought Leadership: Evidence-Based Intelligence. (09:03) - The Role of Consultants in Thought Leadership. (11:55) - The Impact of Generative AI on Thought Leadership. (15:04) - Commercialization and Standards in Thought Leadership. (18:00) - The Future of Thought Leadership in a Noisy World. (29:37) - The Eighth P of Marketing: Thought Leadership. (32:27) - ROI of Thought Leadership: A Game Changer. (36:08) - The Role of Presentation in Thought Leadership. (39:43) - Engagement and Sharing: The Dynamics of Thought Leadership. (48:52) - Trust in Thought Leadership: Building Credibility. (51:04) - The Importance of Frequency and Velocity in Thought Leadership. (55:14) - Establishing Trust and Credibility in a Distrustful World.

Send us a textIn this episode, the CPG Guys are joined by Jeff Clark, VP of Product & Commercialization at Walmart Connect, the retail media division of Walmart. Follow Jeff on LinkedIn at: https://www.linkedin.com/in/jeffclark/ Follow Walmart Connect on LinkedIn at: https://www.linkedin.com/company/walmart-connect/ Follow Walmart Connect online at: https://www.walmartconnect.com/ Jeff answers these questions:Walmart Connect has grown from an incubator project to a full funnel media publishing business. What were the pivotal moments from a product innovation perspective that propelled this transformation?How does Walmart Connect differentiate itself from other retail media networks, particularly in leveraging Walmart's unique assets?How do you approach the commercialization of new ad products while ensuring they align with Walmart's customer-centric values?How does Walmart Connect utilize first-party data to provide measurable ROI for advertisers?With the rise of omnichannel shopping, how does Walmart Connect ensure consistent messaging across online and in-store touchpoints?What innovations are being explored to enhance CX in retail media?Can you discuss the integration between Walmart Connect and Scintilla in delivering actionable insights to brands?ExperienceWhat advancements have been made in closed-loop measurement, and how do they benefit advertisers?How is identity resolution handled within Walmart's advertising ecosystem to ensure effective targeting?What are the biggest challenges you foresee for retail media, and how is Walmart Connect preparing to address them?CPG Guys Website: http://cpgguys.com FMCG Guys Website: http://fmcgguys,com ThinkBlue Website: https://www.linkedin.com/company/thinkbluesolutions/ Rhea Raj Website: http://rhearaj.com Katseye Website: https://www.katseye.world/Subscribe to Chain Drug Review here: https://chaindrugreview.com/#/portal/signupSubscribe to Mass Market Retailers here: https://massmarketretailers.com/#/portal/signupDISCLAIMER: The content in this podcast episode is provided for general informational purposes only. By listening to our episode, you understand that no information contained in this episode should be construed as advice from CPGGUYS, LLC or the individual author, hosts, or guests, nor is it intended to be a substitute for research on any subject matter. Reference to any specific product or entity does not constitute an endorsement or recommendation by CPGGUYS, LLC. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent. CPGGUYS LLC expressly disclaims any and all liability or responsibility for any direct, indirect, incidental, special, consequential or other damages arising out of any individual's use of, reference to, or inability to use this podcast or the information we presented in this podcast.

Last year, the Supreme Court changed college sports. Sarah and Beth are taking in the field (no pun intended) to see how the ruling has changed the amateur athletic landscape and how it continues to shift. They discuss NIL (name, image, likeness), transfer portals, and the continued commercialization of the amateur space. Topics Discussed March Madness and Professionalizing College Athletes Outside of Politics: Bodily Fluids and Discomfort Visit our website for complete show notes, premium shows, show merchandise, and more.See omnystudio.com/listener for privacy information.